Newman James W. Jr.
- SEC CIK
- 0001718364
No open-market purchases or sales filed in the past year.
Current role at each company
- ADIL Adial Pharmaceuticals, Inc.Directoras of Jun 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Newman James W. Jr. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Newman James W. Jr.Director | PPurchase | +10.0K | $2.66 | +$26.6K | +100.0%20.0K after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Newman James W. Jr.Director | PPurchase | +15.0K | $2.71 | +$40.7K | +76.4%34.6K after | 2 lots |
| Nov 30, 2021 (view filing) | Nov 26 | 4 days | Newman James W. Jr.Director | PPurchase | +10.0K | $2.85 | +$28.5K | +40.9%34.5K after |